v3.25.1
Fair Value (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value  
REPLACED Summary of the Company's cash equivalents and investments

The following table summarizes the Company’s financial instruments that were measured at fair value on a non-recurring basis as of March 31, 2025:

Gross

Gross

Amortized

unrecognized

unrecognized

Aggregate

Description

    

Classification

    

cost

    

holding gains

    

holding losses

    

fair value

Money market funds and cash equivalents

 

Cash equivalents

$

20,763

$

$

$

20,763

Commercial paper

 

Short-term investments

 

30,617

3

(6)

 

30,614

U.S. Treasury securities and government agency bonds

Short-term investments

65,784

121

(5)

65,900

Corporate debt

 

Short-term investments

 

18,484

18

(2)

 

18,500

Corporate debt

Long-term investments

6,877

3

6,880

U.S. Treasury securities and government agency bonds

Long-term investments

29,546

107

(20)

29,633

Total cash equivalents, short-term investments and long-term investments

 

  

$

172,071

$

252

$

(33)

$

172,290

The following table summarizes the Company’s financial instruments that were measured at fair value on a non-recurring basis as of December 31, 2024:

Gross

Gross

Amortized

unrecognized

unrecognized

Aggregate

Description

    

Classification

    

cost

    

holding gains

    

holding losses

    

fair value

Money market funds and cash equivalents

 

Cash equivalents

$

19,759

$

$

$

19,759

Commercial paper

Cash equivalents

5,959

1

5,960

Commercial paper

 

Short-term investments

 

47,907

 

28

 

(8)

 

47,927

U.S. Treasury securities and government agency bonds

Short‑term investments

 

64,193

 

135

 

(4)

 

64,324

Corporate debt

Short‑term investments

14,498

29

(6)

14,521

U.S. Treasury securities and government agency bonds

Long-term investments

35,781

106

(68)

35,819

Total cash equivalents, short-term investments and long-term investments

 

  

$

188,097

$

299

$

(86)

$

188,310